AliveCor’s mission is to save lives and transform cardiology by delivering intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere.
Jan 8, 2026 · AliveCor filed an antitrust suit, claiming that Apple had violated Section 2 of the Sherman Act, 15 U.S.C. § 2, by denying third-party app developers access to the original heart rate algorithm’s …
The research labeled “Investigational Use” was conducted using AliveCor devices in an investigational manner and explore potential future devices and configurations.
Apr 3, 2024 · Patent Owner argues that “[Petitioner] AliveCor’s mapping to Molettiere implicates Figure 8 (or Figure 18) for the recited ‘graph representation,’ but refers only to Figure 16 for the recited …
Looking back at how AliveCor’s business models have evolved over the last decade, it is evident that start-ups need to be responsive and adapt to ever-changing trends in health technology adoption, …
Administration (“FDA”), AliveCor obtained approval to sell the KardiaBand in the U.S. Consistent with its history with Apple so far (which involved multiple meetings in which AliveCor demonstrated its new …
AliveCor gewährleistet dem Eigentümer, dass das Produkt seinen veröffentlichten Spezifikationen im Wesentlichen entspricht und dass es bei normaler Verwendung für einen Zeitraum von EINEM JAHR …